Earnings Summary

Hutchison China Meditech Limited’s revenue jumped 163.74% since last year same period to $266.44Mn in the Q2 2023. On a quarterly growth basis, Hutchison China Meditech Limited has generated 0% jump in its revenue since last 3-months.

Hutchison China Meditech Limited’s net profit jumped 203.49% since last year same period to $84.28Mn in the Q2 2023. On a quarterly growth basis, Hutchison China Meditech Limited has generated 0% jump in its net profits since last 3-months.

Hutchison China Meditech Limited’s net profit margin jumped 139.24% since last year same period to 31.63% in the Q2 2023. On a quarterly growth basis, Hutchison China Meditech Limited has generated 0% jump in its net profit margins since last 3-months.

Hutchison China Meditech Limited’s price-to-earnings ratio after this Q2 2023 earnings stands at 27.5.

Hutchison China Meditech Limited’s earning per share (EPS) estimates for the current quarter stand at -1.08 - a -2560.14% fall from last quarter’s estimates.

Hutchison China Meditech Limited’s earning per share (EPS) estimates for the current year stand at -1.08.

Hutchison China Meditech Limited’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q4 2023. This indicates that the Hutchison China Meditech Limited has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.